NCT06356207 Syncope-Asystole Latency Time in Tilt Table Test: The SALT-TILT Study
| NCT ID | NCT06356207 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Azienda Ospedaliera di Bolzano |
| Condition | Syncope |
| Study Type | OBSERVATIONAL |
| Enrollment | 64 participants |
| Start Date | 2024-03-20 |
| Primary Completion | 2026-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 64 participants in total. It began in 2024-03-20 with a primary completion date of 2026-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Syncope is a common presenting condition. Pacemaker implantation can significantly reduce syncope recurrences in reflex syncope. However, despite careful selection, a substantial proportion of patients treated with pacemakers suffer recurrences of syncope. It is thought that a pronounced vasodepressor component may hinder the efficacy of pacing in patients, preventing adequate cerebral perfusion during the reflex, thus relativizing the anti-bradycardia function of the pacemaker to prevent syncope. It is hypothesised that the time elapsed from the actual loss of consciousness to the asystole recorded on the ECG during Tilt Table Test may be predictive in terms of response to pacemaker therapy, so this parameter becomes the subject of the present study.
Eligibility Criteria
Inclusion Criteria: * Patients eligible for invasive treatment according to the ESC Guidelines for pacing 2021 * Written informed consent Exclusion Criteria: * Other condition which explains syncope cause other than reflex syncope * Structural heart disease (valvular, ischaemic, cardiomyopathies) * Pregnancy * Patient denial to be recorded on video during tilt table test
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06356207 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Syncope. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06356207 currently recruiting?
Yes, NCT06356207 is actively recruiting participants. Contact the research team at matthias.unterhuber@gmail.com for enrollment information.
Where is the NCT06356207 trial being conducted?
This trial is being conducted at Bolzano, Italy.
Who is sponsoring the NCT06356207 clinical trial?
NCT06356207 is sponsored by Azienda Ospedaliera di Bolzano. The trial plans to enroll 64 participants.